FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan Egebjerg

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

Anatomy

Procedures

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Simone Guadagna; Nanna Hovelsø; Christoffer Bundgaard; Jan Egebjerg; Paul T Francis; Christiane Volbracht; Florence Sotty
Memantine potentiates hippocampal θ oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties.
Nicole A Datson; Inge E M de Jong; E Ronald de Kloet; Jan Egebjerg; Pekka Kallunki; Erik B Nielsen; Krzysztof Potempa; Niels Speksnijder; Peter Steenbergen; Jan Torleif Pedersen; Kenneth Vielsted Christensen; Michael Didriksen
Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility?
Jens Leander Johansen; Thomas Nikolaj Sager; Julie Lotharius; Louise Witten; Arne Mørk; Jan Egebjerg; Kenneth Thirstrup
HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan Egebjerg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Simone Guadagna; Nanna Hovelsø; Christoffer Bundgaard; Jan Egebjerg; Paul T Francis; Christiane Volbracht; Florence Sotty
Memantine potentiates hippocampal θ oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties.
Neuropharmacology 2012;62(7):2208-18.
2011: Nicole A Datson; Inge E M de Jong; E Ronald de Kloet; Jan Egebjerg; Pekka Kallunki; Erik B Nielsen; Krzysztof Potempa; Niels Speksnijder; Peter Steenbergen; Jan Torleif Pedersen; Kenneth Vielsted Christensen; Michael Didriksen
Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility?
Psychopharmacology 2011;217(4):525-38.
2010: Jens Leander Johansen; Thomas Nikolaj Sager; Julie Lotharius; Louise Witten; Arne Mørk; Jan Egebjerg; Kenneth Thirstrup
HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells.
Journal of neurochemistry 2010;115(1):209-19.
2010: Hanne Poulsen; Himanshu Khandelia; J Preben Morth; Maike Bublitz; Ole G Mouritsen; Jan Egebjerg; Poul Nissen
Neurological disease mutations compromise a C-terminal ion pathway in the Na(+)/K(+)-ATPase.
Nature 2010;467(7311):99-102.
2010: Hanne Poulsen; Preben Morth; Jan Egebjerg; Poul Nissen
Phosphorylation of the Na+,K+-ATPase and the H+,K+-ATPase.
FEBS letters 2010;584(12):2589-95.
2010: Xiaole Wang; Helle Hald; Heidi A Ernst; Jan Egebjerg; Kenneth Vielsted Christensen; Michael Gajhede; Jette S Kastrup; Osman Mirza
Over-expression, purification and characterization of an Asc-1 homologue from Gloeobacter violaceus.
Protein expression and purification 2010;71(2):179-83.
2010: Jacob Andersen; Lars Olsen; Kasper B Hansen; Olivier Taboureau; Flemming S Jørgensen; Anne Marie Jørgensen; Benny Bang-Andersen; Jan Egebjerg; Kristian Strømgaard; Anders Skov Kristensen
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
The Journal of biological chemistry 2010;285(3):2051-63.
2010: Kenneth Vielsted Christensen; Henrik Leffers; William P Watson; Connie Sánchez; Pekka Kallunki; Jan Egebjerg
Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats.
BMC neuroscience 2010;11():9.
2009: Huailing Zhong; Kasper B Hansen; Noel J Boyle; Kiho Han; Galina Muske; Xinyan Huang; Jan Egebjerg; Connie Sánchez
An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
Neuroscience letters 2009;462(3):207-12.
2009: TN Rasmussen; Per Plenge; Tina Bay; Jan Egebjerg; Ulrik Gether
A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation.
Neuropharmacology 2009;57(3):287-94.
2009: Jacob Andersen; Olivier Taboureau; Kasper B Hansen; Lars Olsen; Jan Egebjerg; Kristian Strømgaard; Anders Skov Kristensen
Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
The Journal of biological chemistry 2009;284(15):10276-84.
2008: Rasmus P Clausen; Caspar Christensen; Kasper B Hansen; Jeremy R Greenwood; Lars Jørgensen; Nicola Micale; Jens Christian Madsen; Birgitte Nielsen; Jan Egebjerg; Hans Bräuner-Osborne; Stephen F Traynelis; Jesper L Kristensen
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligands.
Journal of medicinal chemistry 2008;51(14):4179-87.
2008: Ib V Klewe; Søren M Nielsen; Louise Tarpø; Eneko Urizar; Concetta Dipace; Jonathan A Javitch; Ulrik Gether; Jan Egebjerg; Kenneth Vielsted Christensen
Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
Neuropharmacology 2008;54(8):1215-22.
2008: Kasper B Hansen; Hans Bräuner-Osborne; Jan Egebjerg
Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements.
Combinatorial chemistry & high throughput screening 2008;11(4):304-15.
2007: Brian S Rasmussen; Jan Mondrup Pedersen; Jesper Sørensen; Jan Egebjerg; Birgit Schiøtt; Kim Kusk Mortensen; Troels Skrydstrup
Enantioselective proteins: selection, binding studies and molecular modeling of antibodies with affinity towards hydrophobic BINOL derivatives.
Chembiochem : a European journal of chemical biology 2007;8(16):1974-80.
2007: Helle Hald; Peter Naur; Darryl S Pickering; Desiree Sprogøe; Ulf Madsen; Daniel B Timmermann; Philip K Ahring; Tommy Liljefors; Arne Schousboe; Jan Egebjerg; Michael Gajhede; Jette S Kastrup
Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
The Journal of biological chemistry 2007;282(35):25726-36.
2007: Peter Naur; Kasper B Hansen; Anders Skov Kristensen; Shashank M Dravid; Darryl S Pickering; Lars Olsen; Bente Vestergaard; Jan Egebjerg; Michael Gajhede; Stephen F Traynelis; Jette S Kastrup
Ionotropic glutamate-like receptor delta2 binds D-serine and glycine.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(35):14116-21.
2007: Anders A Jensen; Thomas Christesen; Ulrik Bølcho; Jeremy R Greenwood; Giovanna Postorino; Stine B Vogensen; Tommy N Johansen; Jan Egebjerg; Hans Bräuner-Osborne; Rasmus P Clausen
Functional characterization of Tet-AMPA [tetrazolyl-2-amino-3-(3-hydroxy-5-methyl- 4-isoxazolyl)propionic acid] analogues at ionotropic glutamate receptors GluR1-GluR4. The molecular basis for the functional selectivity profile of 2-Bn-Tet-AMPA.
Journal of medicinal chemistry 2007;50(17):4177-85.
2007: Stine B Vogensen; Karla Frydenvang; Jeremy R Greenwood; Giovanna Postorino; Birgitte Nielsen; Darryl S Pickering; Bjarke Ebert; Ulrik Bølcho; Jan Egebjerg; Michael Gajhede; Jette S Kastrup; Tommy N Johansen; Rasmus P Clausen; Povl Krogsgaard-Larsen
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
Journal of medicinal chemistry 2007;50(10):2408-14.
2006: Trine F Andersen; Denis B Tikhonov; Ulrik Bølcho; Konstantin Bolshakov; Jared K Nelson; Florentina Pluteanu; Ian R Mellor; Jan Egebjerg; Kristian Strømgaard
Uncompetitive antagonism of AMPA receptors: Mechanistic insights from studies of polyamine toxin derivatives.
Journal of medicinal chemistry 2006;49(18):5414-23.
2006: Hanne Poulsen; Rasmus Jorgensen; Anders Heding; Omid Niazi; Bjarne Bonven; Jan Egebjerg
Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain.
RNA (New York, N.Y.) 2006;12(7):1350-60.
2006: Lars S Jensen; Ulrik Bølcho; Jan Egebjerg; Kristian Strømgaard
Design, synthesis, and pharmacological characterization of polyamine toxin derivatives: potent ligands for the pore-forming region of AMPA receptors.
ChemMedChem 2006;1(4):419-28.
2005: Kasper B Hansen; Rasmus P Clausen; Esben J Bjerrum; Christian Bechmann; Jeremy R Greenwood; Caspar Christensen; Jesper L Kristensen; Jan Egebjerg; Hans Bräuner-Osborne
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
Molecular pharmacology 2005;68(6):1510-23.
2005: Silke Penschuck; Jesper F Bastlund; Henrik Sindal Jensen; Tine Bryan Stensbol; Jan Egebjerg; William P Watson
Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy.
Brain research. Molecular brain research 2005;141(1):66-73.
2005: Mai Marie Holm; Peter Naur; Bente Vestergaard; Matthew T Geballe; Michael Gajhede; Jette S Kastrup; Stephen F Traynelis; Jan Egebjerg
A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
The Journal of biological chemistry 2005;280(42):35469-76.
2005: Paola Conti; Marco De Amici; Giovanni Grazioso; Gabriella Roda; Andrea Pinto; Kasper B Hansen; Birgitte Nielsen; Ulf Madsen; Hans Bräuner-Osborne; Jan Egebjerg; Valentina Vestri; Domenico E Pellegrini-Giampietro; Pauline Sibille; Francine Acher; Carlo De Micheli
Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Journal of medicinal chemistry 2005;48(20):6315-25.
2005: Bente Frølund; Jeremy R Greenwood; Mai Marie Holm; Jan Egebjerg; Ulf Madsen; Birgitte Nielsen; Hans Bräuner-Osborne; Tine B Stensbøl; Povl Krogsgaard-Larsen
Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
Bioorganic & medicinal chemistry 2005;13(18):5391-8.
2005: Mai Marie Holm; Marie-Louise Lunn; Stephen F Traynelis; Jette S Kastrup; Jan Egebjerg
Structural determinants of agonist-specific kinetics at the ionotropic glutamate receptor 2.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(34):12053-8.
2005: Trine Elkjaer Crovato; Jan Egebjerg
ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicing.
FEBS letters 2005;579(19):4138-44.
2005: Søren Christensen; Jan Egebjerg
Cloning, expression and characterization of a sialidase gene from Arthrobacter ureafaciens.
Biotechnology and applied biochemistry 2005;41(Pt 3):225-31.
2005: Petrine Wellendorph; Kasper B Hansen; Anders Balsgaard; Jeremy R Greenwood; Jan Egebjerg; Hans Bräuner-Osborne
Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids.
Molecular pharmacology 2005;67(3):589-97.
2005: Peter Naur; Bente Vestergaard; Lars K Skov; Jan Egebjerg; Michael Gajhede; Jette S Kastrup
Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
FEBS letters 2005;579(5):1154-60.
2004: Rasmus P Clausen; Kasper B Hansen; Patrizia Calí; Birgitte Nielsen; Jeremy R Greenwood; Mikael Begtrup; Jan Egebjerg; Hans Bräuner-Osborne
The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
European journal of pharmacology 2004;499(1-2):35-44.
2004: Lotte Brehm; Jeremy R Greenwood; Frank A Sløk; Mai Marie Holm; Birgitte Nielsen; Ulla Geneser; Tine B Stensbøl; Hans Bräuner-Osborne; Mikael Begtrup; Jan Egebjerg; Povl Krogsgaard-Larsen
Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Chirality 2004;16(7):452-66.
2004: Jens A Lundbaek; Pia Birn; Anders J Hansen; Rikke Søgaard; Claus Helix-Nielsen; Jeffrey Girshman; Michael J Bruno; Sonya E Tape; Jan Egebjerg; Denise V Greathouse; Gwendolyn L Mattice; Roger E Koeppe; Olaf S Andersen
Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol.
The Journal of general physiology 2004;123(5):599-621.
2003: Lone Helboe; Jan Egebjerg; Morten Møller; Christian Thomsen
Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain.
The European journal of neuroscience 2003;18(8):2227-38.
2003: Lotte Brehm; Jeremy R Greenwood; Kasper B Hansen; Birgitte Nielsen; Jan Egebjerg; Tine B Stensbøl; Hans Bräuner-Osborne; Frank A Sløk; Tine T A Kronborg; Povl Krogsgaard-Larsen
(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
Journal of medicinal chemistry 2003;46(8):1350-8.
2003: Marie-Louise Lunn; Anders Hogner; Tine B Stensbøl; James Eric Gouaux; Jan Egebjerg; Jette S Kastrup
Three-dimensional structure of the ligand-binding core of GluR2 in complex with the agonist (S)-ATPA: implications for receptor subunit selectivity.
Journal of medicinal chemistry 2003;46(5):872-5.
2003: Anders Hogner; Jeremy R Greenwood; Tommy Liljefors; Marie-Louise Lunn; Jan Egebjerg; Ingrid K Larsen; James Eric Gouaux; Jette S Kastrup
Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX.
Journal of medicinal chemistry 2003;46(2):214-21.
2003: Morten Muhlig Nielsen; Tommy Liljefors; Povl Krogsgaard-Larsen; Jan Egebjerg
The selective activation of the glutamate receptor GluR5 by ATPA is controlled by serine 741.
Molecular pharmacology 2003;63(1):19-25.
2002: Hasse Kromann; Sonata Krikstolaityte; Anne J Andersen; Kim Andersen; Povl Krogsgaard-Larsen; Jerzy W Jaroszewski; Jan Egebjerg; Kristian Strømgaard
Solid-phase synthesis of polyamine toxin analogues: potent and selective antagonists of Ca2+-permeable AMPA receptors.
Journal of medicinal chemistry 2002;45(26):5745-54.
2002: Christina Kasper; Marie-Louise Lunn; Tommy Liljefors; James Eric Gouaux; Jan Egebjerg; Jette S Kastrup
GluR2 ligand-binding core complexes: importance of the isoxazolol moiety and 5-substituent for the binding mode of AMPA-type agonists.
FEBS letters 2002;531(2):173-8.
2002: Anders Hogner; Jette S Kastrup; R Jin; Tommy Liljefors; Mark L Mayer; Jan Egebjerg; Ingrid K Larsen; James Eric Gouaux
Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
Journal of molecular biology 2002;322(1):93-109.
2002: Michael Dabrowski; Frances M Ashcroft; Rebecca Ashfield; Philippe Lebrun; Bernard Pirotte; Jan Egebjerg; John Bondo Hansen; Philip Wahl
The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener.
Diabetes 2002;51(6):1896-906.
2002: Wei-Min Dai; Kenneth Vielsted Christensen; Jan Egebjerg; Bjarke Ebert; John D C Lambert
Correlation of the expression of kainate receptor subtypes to responses evoked in cultured cortical and spinal cord neurones.
Brain research 2002;926(1-2):94-107.
2001: H Poulsen; Jakob Nilsson; Christian K Damgaard; Jan Egebjerg; Jørgen Kjems
CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.
Molecular and cellular biology 2001;21(22):7862-71.
2001: Wei-Min Dai; Jan Egebjerg; John D C Lambert
Characteristics of AMPA receptor-mediated responses of cultured cortical and spinal cord neurones and their correlation to the expression of glutamate receptor subunits, GluR1-4.
British journal of pharmacology 2001;132(8):1859-75.
2001: Tine B Stensbøl; Henrik Sindal Jensen; Birgitte Nielsen; Tommy N Johansen; Jan Egebjerg; Karla Frydenvang; Povl Krogsgaard-Larsen
Stereochemistry and molecular pharmacology of (S)-thio-ATPA, a new potent and selective GluR5 agonist.
European journal of pharmacology 2001;411(3):245-53.
2000: Kenneth Vielsted Christensen; Wei-Min Dai; John D C Lambert; Jan Egebjerg
Larger intercellular variation in (Q/R) editing of GluR6 than GluR5 revealed by single cell RT-PCR.
Neuroreport 2000;11(16):3577-82.
2000: Stine B Vogensen; Henrik Sindal Jensen; Tine B Stensbøl; Karla Frydenvang; Benny Bang-Andersen; Tommy N Johansen; Jan Egebjerg; Povl Krogsgaard-Larsen
Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist.
Chirality 2000;12(10):705-13.
2000: Hans Bräuner-Osborne; Jan Egebjerg; Elsebet O Nielsen; Ulf Madsen; Povl Krogsgaard-Larsen
Ligands for glutamate receptors: design and therapeutic prospects.
Journal of medicinal chemistry 2000;43(14):2609-45.
1999: Tine B Stensbøl; L Borre; Tommy N Johansen; Jan Egebjerg; Ulf Madsen; Bjarke Ebert; P Krogsgaard-Larsen
Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA.
European journal of pharmacology 1999;380(2-3):153-62.
1999: Tine B Stensbøl; Frank A Sløk; J Trometer; S Hurt; Bjarke Ebert; C Kjøller; Jan Egebjerg; Ulf Madsen; Nils Henrik Diemer; Povl Krogsgaard-Larsen
Characterization of a new AMPA receptor radioligand, [3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid.
European journal of pharmacology 1999;373(2-3):251-62.
1999: E H Møller; Jan Egebjerg; Lotte Brehm; Tine B Stensbøl; Tommy N Johansen; Ulf Madsen; Povl Krogsgaard-Larsen
Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
Chirality 1999;11(10):752-9.
1998: Kim Kusk Mortensen; J Kildsgaard; Juan Manuel Palacios Moreno; SA Steffensen; Jan Egebjerg; Hans Uffe Sperling-Petersen
A six-domain structural model for Escherichia coli translation initiation factor IF2. Characterisation of twelve surface epitopes.
Biochemistry and molecular biology international 1998;46(5):1027-41.
1998: P Ostergaard; Hien Phan; L B Johansen; Jan Egebjerg; L Ostergaard; Bo T Porse; Roger A Garrett
Assembly of proteins and 5 S rRNA to transcripts of the major structural domains of 23 S rRNA.
Journal of molecular biology 1998;284(2):227-40.
1998: P Wahl; C Anker; Stephen F Traynelis; Jan Egebjerg; J S Rasmussen; P Krogsgaard-Larsen; Ulf Madsen
Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes.
Molecular pharmacology 1998;53(3):590-6.
1998: Jørgen Kjems; Jan Egebjerg
Modern methods for probing RNA structure.
Current opinion in biotechnology 1998;9(1):59-65.
1997: P Holst-Hansen; J Kildsgaard; Jane MacDougall; J M Palacios Moreno; Jan Egebjerg; Kim Kusk Mortensen; Hans Uffe Sperling-Petersen
Immunochemical determination of the cellular content of polypeptide chain release factor RF3 in Escherichia coli.
Biochimie 1997;79(12):725-9.
1994: Jan Egebjerg; V Kukekov; Stephen F Heinemann
Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(22):10270-4.
1994: R B Puchalski; J C Louis; N Brose; Stephen F Traynelis; Jan Egebjerg; V Kukekov; Robert Wenthold; Scott W Rogers; F Lin; T Moran
Selective RNA editing and subunit assembly of native glutamate receptors.
Neuron 1994;13(1):131-47.
1993: Jan Egebjerg; Stephen F Heinemann
Ca2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(2):755-9.
1992: Bernhard Bettler; Jan Egebjerg; G Sharma; G Pecht; I Hermans-Borgmeyer; C Moll; C F Stevens; S Heinemann
Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit.
Neuron 1992;8(2):257-65.
1991: Jan Egebjerg; J Christiansen; Roger A Garrett
Attachment sites of primary binding proteins L1, L2 and L23 on 23 S ribosomal RNA of Escherichia coli.
Journal of molecular biology 1991;222(2):251-64.
1991: Jan Egebjerg; Roger A Garrett
Binding sites of the antibiotics pactamycin and celesticetin on ribosomal RNAs.
Biochimie 1991;73(7-8):1145-9.
1991: Jan Egebjerg; Bernhard Bettler; I Hermans-Borgmeyer; S Heinemann
Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA.
Nature 1991;351(6329):745-8.
1990: Jan Egebjerg; S R Douthwaite; A Liljas; Roger A Garrett
Characterization of the binding sites of protein L11 and the L10.(L12)4 pentameric complex in the GTPase domain of 23 S ribosomal RNA from Escherichia coli.
Journal of molecular biology 1990;213(2):275-88.
1989: Jan Egebjerg; J Christiansen; R S Brown; N Larsen; Roger A Garrett
Protein L18 binds primarily at the junctions of helix II and internal loops A and B in Escherichia coli 5 S RNA. Implications for 5 S RNA structure.
Journal of molecular biology 1989;206(4):651-68.
1989: Jan Egebjerg; S Douthwaite; Roger A Garrett
Antibiotic interactions at the GTPase-associated centre within Escherichia coli 23S rRNA.
The EMBO journal 1989;8(2):607-11.
1988: H Leffers; Jan Egebjerg; A Andersen; T Christensen; Roger A Garrett
Domain VI of Escherichia coli 23 S ribosomal RNA. Structure, assembly and function.
Journal of molecular biology 1988;204(3):507-22.
1987: Jan Egebjerg; H Leffers; A Christensen; H Andersen; Roger A Garrett
Structure and accessibility of domain I of Escherichia coli 23 S RNA in free RNA, in the L24-RNA complex and in 50 S subunits. Implications for ribosomal assembly.
Journal of molecular biology 1987;196(1):125-36.